Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy

Robin Jacob, Paolo Strati, Nicolas Palaskas, Juan C. Lopez-Mattei, Konstantinos Marmagkiolis, L. Maximilian Buja, Anita Deswal, Cezar Iliescu

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

A 66-year-old woman with follicular lymphoma on lenalidomide and rituximab presented with chest pain. High-sensitivity troponin T peaked at 7,566 ng/l. Cardiac biopsy revealed extensive inflammation consistent with medication-induced myocarditis. Lenalidomide was stopped with improvement in troponins and patient was initiated on high-dose corticosteroid therapy. (Level of Difficulty: Intermediate.)

Original languageEnglish (US)
Pages (from-to)2095-2100
Number of pages6
JournalJACC: Case Reports
Volume2
Issue number13
DOIs
StatePublished - Nov 2020

Keywords

  • cardio-oncology
  • cardiotoxicity
  • follicular lymphoma
  • lenalidomide
  • myocarditis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy'. Together they form a unique fingerprint.

Cite this